- Approval Id
- eff65138ae900d51
- Drug Name
- EROGRAN FOR ORAL SUSPENSION 200 mg/5 ml
- Product Name
- EROGRAN FOR ORAL SUSPENSION 200 mg/5 ml
- Approval Number
- SIN08042P
- Approval Date
- 1995-02-23
- Registrant
- GOLDPLUS UNIVERSAL PTE LTD
- Licence Holder
- GOLDPLUS UNIVERSAL PTE LTD
- Drug Type
- Therapeutic
- Forensic Classification
- Prescription Only
- Dosage Form
- GRANULE, FOR SUSPENSION
- Dosage
- **DOSAGE AND ADMINISTRATION**
**Adults**
- **Antibacterial**
Oral, the equivalent of erythromycin 400 mg every 6 hours or 800 mg every 12 hours.
- **Antibacterial (streptococcal prophylaxis)**
- Continuous prophylaxis of streptococcal infections in patients with a history of rheumatic heart disease and/or chorea.
- Oral, the equivalent of erythromycin 400 mg every 12 hours.
- **Antiprotozoal**
Oral, the equivalent of erythromycin 400 mg every 6 hours for ten to fourteen days.
- **Gonorrhoea (disseminated)**
Oral, the equivalent of erythromycin 800 mg every 6 hours for seven days.
- **Legionaires' Disease**
Oral, the equivalent of erythromycin 400 mg to 1 gram every 6 hours.
- **Syphilis**
Oral, the equivalent of erythromycin 800 mg every 6 hours for 15 days (early syphilis) or for 30 days (late syphilis).
**Usual adult prescribing limits**
Antibacterial the equivalent of erythromycin up to 4 grams daily.
Note: Doses up to the equivalent of 8 grams of erythromycin daily are apparently well tolerated.
**Children**
- **Antibacterial**
Oral, the equivalent of erythromycin 7.5 to 25 mg per kg of body weight every 6 hours or 15 to 50 mg per kg of body weight every 12 hours.
- **Antiprotozoal**
Oral, the equivalent of erythromycin 7.5 to 12.5 mg per kg of body weight every 6 hours for 10 to 14 days.
Note: 1.17 grams of erythromycin ethylsuccinate are equivalent to approximately 1 gram of erythromycin.
To reconstitute, add cooled boiled water until well dispersed, then add water to the appropriate mark.
Note: The information given here is limited. For further information, consult your doctor or pharmacist.
- Route Of Administration
- ORAL
- Indication Info
- **INDICATIONS**
Indicated in the treatment or prophylaxis of the following:
- Upper and lower respiratory tract infections.
- Skin and soft-tissue infections including erythrasma.
- Genitourinary tract infections including gonorrhoea and syphilis.
- Intestinal amoebiasis.
- Others include bacterial endocarditis, streptococcal pharyngitis, diphtheria, Legionnaires' disease and pertussis.
- Contraindications
- **CONTRAINDICATIONS**
- Avoid in patients known to be hypersensitive to erythromycins
- Erythromycin is contraindicated in patients taking astemizole, terfenadine, domperidone, cisapride or pimozide
- Erythromycin should not be given to patients with a history of QT prolongation (congenital or documented acquired QT prolongation) or ventricular cardiac arrhythmia, including torsades de pointes (see "Warnings and Precautions" – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_)
- Erythromycin should not be given to patients with electrolyte disturbances (hypokalaemia, hypomagnesaemia due to the risk of prolongation of QT interval)
- Atc Code
- J01FA01
- Atc Item Name
- erythromycin
- Pharma Manufacturer Name
- GOLDPLUS UNIVERSAL PTE LTD
- Company Detail Path
- /organization/goldplus-universal-pte-ltd
